BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8776617)

  • 1. Inhibitory effects of interleukin-4 on human renal cell carcinoma cells in vitro: in combination with interferon-alpha, tumor necrosis factor-alpha or interleukin-2.
    Cheon J; Chung DJ; Kim JJ; Koh SK; Sohn J
    Int J Urol; 1996 May; 3(3):196-201. PubMed ID: 8776617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-alpha and/or interferon-gamma.
    Iwasaki K; Rogers LR; Estes ML; Barna BP
    Neurosurgery; 1993 Sep; 33(3):489-93; discussion 493-4. PubMed ID: 8413882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.
    van Valen F; Winkelmann W; Burdach S; Göbel U; Jürgens H
    J Cancer Res Clin Oncol; 1993; 119(10):615-21. PubMed ID: 8335680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
    Hoon DS; Okun E; Banez M; Irie RF; Morton DL
    Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
    Bassukas ID; Hofmockel G; Maurer-Schultze B
    Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of four different cytokines on renal carcinoma cell lines.
    Buszello H
    Anticancer Res; 1995; 15(3):735-8. PubMed ID: 7645950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 and renal cell cancer: production, regulation, and growth effects.
    Koo AS; Armstrong C; Bochner B; Shimabukuro T; Tso CL; deKernion JB; Belldegrum A
    Cancer Immunol Immunother; 1992; 35(2):97-105. PubMed ID: 1596939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.
    Falkensammer C; Jöhrer K; Gander H; Ramoner R; Putz T; Rahm A; Greil R; Bartsch G; Thurnher M
    Cancer Immunol Immunother; 2006 Oct; 55(10):1228-37. PubMed ID: 16810557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS; Banez M; Okun E; Morton DL; Irie RF
    Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
    Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
    J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia.
    Carter A; Silvian-Draxler I; Tatarsky I
    Am J Hematol; 1992 Aug; 40(4):245-51. PubMed ID: 1503080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
    Totpal K; Aggarwal BB
    Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic actions of cytokines and growth factors in enhancing porcine granulosa cell growth.
    Fukuoka M; Yasuda K; Taii S; Mori T
    Endocrinol Jpn; 1992 Jun; 39(3):277-88. PubMed ID: 1425452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines.
    Ohta K; Pang XP; Berg L; Hershman JM
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2607-12. PubMed ID: 8675585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
    Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
    Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.